Management of women at increased risk for hereditary breast cancerSMITH, Karen Lisa; ISAACS, Claudine.Breast disease. 2006, Vol 27, pp 51-67, issn 0888-6008, 17 p.Article

New prognostic factors for breast cancer recurrenceISAACS, Claudine; STEARNS, Vered; HAYES, Daniel F et al.Seminars in oncology. 2001, Vol 28, Num 1, pp 53-67, issn 0093-7754Article

Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: Testing among Ashkenazi Jewish womenSCHWARTZ, Marc D; BENKENDORF, Judith; LERMAN, Caryn et al.Cancer. 2001, Vol 92, Num 4, pp 932-940, issn 0008-543XArticle

BRCA1/2 mutations and triple negative breast cancersPESHKIN, Beth N; ALABEK, Michelle L; ISAACS, Claudine et al.Breast disease. 2011, Vol 32, Num 1-2, pp 25-33, issn 0888-6008, 9 p.Article

Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: A pilot survey of physiciansPESHKIN, Beth N; ISAACS, Claudine; FINCH, Clinton et al.Journal of clinical oncology. 2003, Vol 21, Num 23, pp 4322-4328, issn 0732-183X, 7 p.Article

Hot flushesSTEARNS, Vered; ULLMER, Lynda; LOPEZ, Juan F et al.Lancet (British edition). 2002, Vol 360, Num 9348, pp 1851-1861, issn 0140-6736, 11 p.Article

BRCA1/2 testing : complex themes in result interpretationPESHKIN, Beth N; DEMARCO, Tiffani A; BROGAN, Barbara M et al.Journal of clinical oncology. 2001, Vol 19, Num 9, pp 2555-2565, issn 0732-183XArticle

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sampleSCHWARTZ, Marc D; PESHKIN, Beth N; HUGHES, Chanita et al.Journal of clinical oncology. 2002, Vol 20, Num 2, pp 514-520, issn 0732-183XArticle

Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancerISAACS, Claudine; PESHKIN, Beth N; SCHWARTZ, Marc et al.Breast cancer research and treatment. 2002, Vol 71, Num 2, pp 103-112, issn 0167-6806Article

Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testingPESHKIN, Beth N; SCHWARTZ, Marc D; ISAACS, Claudine et al.Cancer epidemiology, biomarkers & prevention. 2002, Vol 11, Num 10, pp 1115-1118, issn 1055-9965, 4 p., 1Article

Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers : an updateGINSBURG, Ophira; GHADIRIAN, Parviz; KLIJN, Jan et al.Breast cancer research and treatment. 2009, Vol 114, Num 1, pp 127-135, issn 0167-6806, 9 p.Article

Randomized Trial of a Decision Aid for BRCA1/BRCA2 Mutation Carriers : Impact on Measures of Decision Making and SatisfactionSCHWARTZ, Marc D; DEMARCO, Tiffani A; O'NEILL, Suzanne et al.Health psychology (Hillsdale, N.J.). 2009, Vol 28, Num 1, pp 11-19, issn 0278-6133, 9 p.Article

Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation CarriersEISEN, Andrea; LUBINSKI, Jan; MANOUKIAN, Siranoush et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 19, pp 1361-1367, issn 0027-8874, 7 p.Article

The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancersMARCOM, P. Kelly; ISAACS, Claudine; HARRIS, Lyndsay et al.Breast cancer research and treatment. 2007, Vol 102, Num 1, pp 43-49, issn 0167-6806, 7 p.Article

RAD51 135G→C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers : Results from a Combined Analysis of 19 StudiesANTONIOU, Antonis C; SINILNIKOVA, Olga M; COUPIER, Isabelle et al.American journal of human genetics. 2007, Vol 81, Num 6, pp 1186-1200, issn 0002-9297, 15 p.Article

Characterization of BRCA1 and BRCA2 mutations in a large United States sampleSINING CHEN; IVERSEN, Edwin S; CORIO, Camille et al.Journal of clinical oncology. 2006, Vol 24, Num 6, pp 863-871, issn 0732-183X, 9 p.Article

A comparison of bilateral breast cancers in BRCA carriersWEITZEL, Jeffrey N; ROBSON, Mark; GHADIRIAN, Parviz et al.Cancer epidemiology, biomarkers & prevention. 2005, Vol 14, Num 6, pp 1534-1538, issn 1055-9965, 5 p.Article

A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patientsISAACS, Claudine; SLACK, Rebecca; GEHAN, Edmund et al.Breast cancer research and treatment. 2005, Vol 93, Num 2, pp 125-134, issn 0167-6806, 10 p.Article

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patientsSCHWARTZ, Marc D; CARYN LERMAN; PENNANEN, Marie et al.Journal of clinical oncology. 2004, Vol 22, Num 10, pp 1823-1829, issn 0732-183X, 7 p.Article

Prognostic factors in breast cancer: Current and new predictors of metastasisHAYES, Daniel F; ISAACS, Claudine; STEARNS, Vered et al.Journal of mammary gland biology and neoplasia. 2001, Vol 6, Num 4, pp 375-392, issn 1083-3021Article

Supplement use during an intergroup clinical trial for breast cancer (S0221)ZIRPOLI, Gary R; BRENNAN, Patrick M; STEWART, James et al.Breast cancer research and treatment. 2013, Vol 137, Num 3, pp 903-913, issn 0167-6806, 11 p.Article

Breast and Ovarian Cancer Risk and Risk Reduction in Jewish BRCA1/2 Mutation CarriersFINKELMAN, Brian S; RUBINSTEIN, Wendy S; OLOPADE, Olufunmilayo I et al.Journal of clinical oncology. 2012, Vol 30, Num 12, pp 1321-1328, issn 0732-183X, 8 p.Article

Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivorsGRAVES, Kristi D; PESHKIN, Beth N; HALBERT, Chanita H et al.Breast cancer research and treatment. 2007, Vol 104, Num 3, pp 321-329, issn 0167-6806, 9 p.Article

Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancerPIERCE, Lori J; LEVIN, Albert M; NAROD, Steven A et al.Journal of clinical oncology. 2006, Vol 24, Num 16, pp 2437-2443, issn 0732-183X, 7 p.Article

Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriersCULLINANE, Carey A; LUBINSKI, Jan; FRIEDMAN, Eitan et al.International journal of cancer. 2005, Vol 117, Num 6, pp 988-991, issn 0020-7136, 4 p.Article